Is it taking longer to die in paediatric intensive care in England and Wales?

Adrian Plunkett1, Roger C Parslow2

  • 1Paediatric Intensive Care Unit, Birmingham Children's Hospital, Birmingham, UK.

Insights

Pediatric critical care advances have prolonged the length of stay for children who die in intensive care units (PICUs). This trend indicates improved survival for acute conditions but extended care for life-limiting illnesses.

Area of Science:

  • Pediatric Critical Care Medicine
  • Mortality Studies
  • Healthcare Informatics

Background:

  • All-cause infant and childhood mortality has declined in the UK over three decades.
  • Advances in pediatric critical care have improved survival rates in pediatric intensive care units (PICUs).
  • These advancements may influence the timing and circumstances of child deaths within PICUs.

Purpose of the Study:

  • To investigate factors influencing the length of stay (LOS) for children who died in PICUs.
  • To analyze trends in LOS for non-survivors over an 11-year period.

Main Methods:

  • Analysis of demographic and clinical data from 165,473 PICU admissions in England and Wales (2003-2013).
  • Assessment of time trends in LOS for both survivors and non-survivors.
  • Exploration of demographic and clinical factors affecting LOS in non-survivors.

Main Results:

  • Length of stay (LOS) increased annually by 0.310 days for non-survivors and 0.064 days for survivors.
  • The proportion of early deaths (<24 hours) decreased, while late deaths (>28 days) increased.
  • The severity of illness (Paediatric Index of Mortality score) in early deaths rose annually.

Conclusions:

  • Increased LOS for deceased children in PICU is linked to fewer early deaths and more late deaths.
  • This suggests improved outcomes for critically ill children but prolonged care for those with life-limiting conditions.
Abstract

Related Concept Videos

Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.5K
Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
726
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
458
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369